Moderna Inc/ US60770K1079 /
2024-04-30 10:00:00 PM | Chg. -1.3100 | Volume | Bid1:47:10 AM | Ask1:47:10 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
110.3100USD | -1.17% | 3.21 mill. Turnover: 240.13 mill. |
110.0500Bid Size: 500 | 110.4900Ask Size: 200 | 42.15 bill.USD | - | - |
GlobeNewswire
04-04
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Aga...
GlobeNewswire
03-04
CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
GlobeNewswire
02-29
Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
GlobeNewswire
01-12
CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Conference